Loading insider details...
Latest Form 4 (Jun 29, 2026): Grant/Award of 40,000 BDTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| Jun 12, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Jun 5, 2025 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 29,747 | n/a |
| Jul 1, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,121,604 | n/a |
| Jun 7, 2024 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 7,639 | n/a |
| Jun 6, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Jul 10, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 47,702 | $43.4K |
| Jul 5, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 736,548 | n/a |
| Jul 3, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 981,463 | n/a |
| Jun 15, 2023 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 19,441 | n/a |